Antenatal dexamethasone and decreased severity of retinopathy of prematurity.
Open Access
- 1 May 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 116 (5), 601-605
- https://doi.org/10.1001/archopht.116.5.601
Abstract
RETINOPATHY OF prematurity (ROP) is a serious vasoproliferative disorder faced by the smallest infants in the modern neonatal intensive care unit. Improved technologies have led the way toward improving the survival of small infants at earlier gestational ages.1 Improving the quality of survival and long-term outcome is of utmost importance. Serious visual problems and blindness continue to be included in the long-term neurologic sequelae of these infants.2,3 As survival of these small infants improves, the causes and treatment of ROP must be addressed or visual outcome will continue to be a problem.Keywords
This publication has 7 references indexed in Scilit:
- Inhibition of Preretinal and Optic Nerve Head Neovascularization in Pigs by Intravitreal Triamcinolone AcetonideOphthalmology, 1996
- Outcomes of Extremely Immature Infants -- A Perinatal DilemmaNew England Journal of Medicine, 1993
- Follow-up study on premature infants with and without retinopathy of prematurity.British Journal of Ophthalmology, 1993
- Development of Myopia in Infants with Birth Weights Less than 1251 GramsOphthalmology, 1992
- Laser Photocoagulation for Stage 3+ Retinopathy of PrematurityOphthalmology, 1991
- Incidence and Characteristics of Retinopathy of Prematurity in a low-income Inner-city PopulationOphthalmology, 1991
- Effects of Intravitreal Administration of Steroids on Experimental Subretinal Neovascularization in the Subhuman PrimateArchives of Ophthalmology (1950), 1985